Trial Profile
A study evaluating effect of CYP3A4 inducer, Carbamazepine on Pharmacokinetics of BIIB-074 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2019
Price :
$35
*
At a glance
- Drugs Vixotrigine (Primary) ; Carbamazepine
- Indications Erythromelalgia; Neuropathic pain; Trigeminal neuralgia
- Focus Pharmacokinetics
- 24 Oct 2019 Results assessing pharmacokinetic interaction between Vixotrigine and Carbamazepine were published in the Clinical Pharmacology in Drug Development
- 28 Sep 2017 New trial record
- 01 Sep 2017 Results published in Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology